Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
Krystyna Tatarkiewicz(Amplyx Pharmaceuticals (United States)), David G. Parkes(Amplyx Pharmaceuticals (United States)), Clara J. Polizzi(Amplyx Pharmaceuticals (United States)), Denis Roy(Amplyx Pharmaceuticals (United States)), Emmanuel J. Sablan(Amplyx Pharmaceuticals (United States)), Donald E. Aumann(Amplyx Pharmaceuticals (United States)), Christiane Villescaz(Amplyx Pharmaceuticals (United States)), Pam Smith(Amplyx Pharmaceuticals (United States)), Tina Whisenant(Amplyx Pharmaceuticals (United States)), Diane M. Hargrove(Amplyx Pharmaceuticals (United States)), Lisa C. Adams(TUM Klinikum), Bronislava Gedulin(Amplyx Pharmaceuticals (United States)), Melissa G. W. Lu(Amplyx Pharmaceuticals (United States))
American Journal of Physiology-Endocrinology and Metabolism
October 6, 2010
Cited by 91
Related Papers
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
|The Lancet|2025|966
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
|Proceedings of the National Academy of Sciences|2008|433
Amylin: Pharmacology, Physiology, and Clinical Potential
|Pharmacological Reviews|2015|395
SenNet recommendations for detecting senescent cells in different tissues
|Nature Reviews Molecular Cell Biology|2024|330